PROTAGONIST THERAPEUTICS INC (PTGX) Stock Balance Sheet
NASDAQ:PTGX - US74366E1029 - Common Stock
57.48 USD
+1.44 (+2.57%)
57.48 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 168.54M | 97.25M | 186.73M | 125.70M | 123.70M | |||
| Marketable Securities | 401.92M | 321.66M | 154.89M | 111.60M | 203.20M | |||
| Receivables | 27.97M | 168.49M | 10.33M | 100.00K | 5.30M | |||
| Other Current Assets | 4.09M | 4.24M | 3.63M | 5.70M | 8.50M | |||
| Total Current Assets | 602.53M | 591.64M | 355.58M | 243.10M | 340.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.70M | 12.61M | 2.15M | 4.60M | 6.70M | |||
| Investments And Advances | 102.49M | 140.25M | N/A | N/A | N/A | |||
| Other Non-Current Assets | 290.00K | 225.00K | 225.00K | 200.00K | 200.00K | |||
| Total Non-Current Assets | 115.48M | 153.08M | 2.37M | 4.80M | 7.00M | |||
| TOTAL ASSETS | 718.01M | 744.73M | 357.95M | 247.90M | 347.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.41M | 24.13M | 20.40M | 27.10M | 39.50M | |||
| Accounts Payable | 3.25M | 1.61M | 772.00K | 3.60M | 1.60M | |||
| Other Current Liabilities | 14.85M | 21.65M | 102.00K | 500.00K | 2.90M | |||
| Total Current Liabilities | 35.51M | 47.40M | 21.27M | 31.20M | 44.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 14.48M | 22.03M | 0.00 | 1.10M | 3.70M | |||
| Total Non-Current Liabilities | 14.48M | 22.03M | 0.00 | 1.10M | 3.70M | |||
| TOTAL LIABILITIES | 49.99M | 69.43M | 21.27M | 32.30M | 47.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -386.95M | -340.52M | -615.71M | -536.80M | -409.40M | |||
| Additional Paid In Capital | 1.05B | 1.02B | 952.49M | 752.70M | 709.70M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -15.00K | -82.00K | -105.00K | -400.00K | -300.00K | |||
| Shares Outstanding | 62.11M | 61.04M | 57.71M | 49.30M | 47.80M | |||
| Tangible Book Value per Share | 10.76 | 11.06 | 5.83 | 4.37 | 6.28 | |||
| Total Shareholders' Equity | 668.02M | 675.29M | 336.68M | 215.60M | 300.00M | |||
| TOTAL LIABILITIES AND EQUITY | 718.01M | 744.73M | 357.95M | 247.90M | 347.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 16.97 | 12.48 | 16.71 | 7.79 | 7.74 | |||
| Return On Assets (ROA) | 7.25% | 36.95% | -22.06% | -51.39% | -36.11% | |||
| Return On Equity (ROE) | 7.79% | 40.75% | -23.45% | -59.09% | -41.85% | |||
| Return On Invested Capital (ROIC) | 2.78% | 28.64% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 16.91% | 71.74% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 16.91% | 71.74% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21